CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Long-Term Debt
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Long-Term Debt of $1.63 billion as of 2018-12-29, per its 10-K filed 2019-02-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2019-02-13
- 2018-12-29: Long-term Debt, Excluding Current Maturities $1.63B.
- 2018-09-29: Long-term Debt, Excluding Current Maturities $1.64B.
- 2018-06-30: Long-term Debt, Excluding Current Maturities $1.79B.
- 2018-03-31: Long-term Debt, Excluding Current Maturities $1.11B.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2018-12-29 | $1.63B 10-K · filed 2019-02-13 |
| 2018-09-29 | $1.64B 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.79B 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.11B 10-Q · filed 2018-05-10 |
| 2017-12-30 | $1.09B 10-K · filed 2019-02-13 |
| 2017-09-30 | $1.13B 10-Q · filed 2017-11-09 |
| 2017-07-01 | $1.09B 10-Q · filed 2017-08-09 |
| 2017-04-01 | $1.15B 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.19B 10-K · filed 2018-02-13 |
| 2016-09-24 | $1.21B 10-Q · filed 2016-11-02 |
| 2016-06-25 | $1.31B 10-Q · filed 2016-08-03 |
| 2016-03-26 | $817.74M 10-Q · filed 2016-05-04 |
| 2015-12-26 | $821.04M 10-K · filed 2017-02-14 |
| 2015-09-26 | $809.87M 10-Q · filed 2015-11-04 |
| 2015-06-27 | $727.89M 10-Q · filed 2015-07-30 |
| 2015-03-28 | $728.44M 10-Q · filed 2015-04-30 |
| 2014-12-27 | $722.04M 10-K · filed 2016-02-12 |
| 2014-09-27 | $737.91M 10-Q · filed 2014-10-30 |
| 2014-06-28 | $771.06M 10-Q · filed 2014-08-07 |
| 2014-03-29 | $613.60M 10-Q · filed 2014-04-30 |
| 2013-12-28 | $641.81M 10-K · filed 2015-02-17 |
| 2013-09-28 | $623.75M 10-Q · filed 2013-10-30 |
| 2013-06-29 | $619.25M 10-Q · filed 2013-07-31 |
| 2013-03-30 | $517.51M 10-Q · filed 2013-05-08 |
| 2012-12-29 | $527.08M 10-K · filed 2014-02-25 |
| 2012-09-29 | $543.14M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $551.39M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $674.74M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $703.17M 10-K · filed 2013-02-27 |
| 2010-12-25 | $670.22M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |